Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyceryl Tribenzoate (GTB) in Healthy Subjects
NCT05938452Phase 1Completed
- Sponsor
- Forest Hills Lab
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of glyceryl tribenzoate (2 arms), sponsored by Forest Hills Lab. Primary endpoints: Treatment-Emergent Adverse Events at 7 days, Treatment-Emergent Adverse Events Withdrawals at 7 days and 4 more. Started Dec 2022; status: completed.
02
Drugs
glyceryl tribenzoate
Beyond the preview
Go deeper on NCT05938452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05938452.